We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Functional-three-dimensional Reconstruction of Liver by 99MTc-GSA-SPECT Scan (GSA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01350726
Recruitment Status : Unknown
Verified May 2011 by Peking Union Medical College Hospital.
Recruitment status was:  Recruiting
First Posted : May 10, 2011
Last Update Posted : May 10, 2011
Information provided by:

Study Description
Brief Summary:

The aims of this study were divided into three parts:

  1. To develop a new software to carry out the functional-three- dimensional-reconstruction of the liver by 99mTc-GSA-SPECT scintigraphy
  2. To probe a new dynamic model of the metabolism of the 99mTc-GSA.
  3. To evaluate the liver function by 99mTc-GSA-SPECT scintigraphy before surgical treatment.

Study design:

  1. Collectivity type: Prospective,randomized, controlled, multi-central clinical study.
  2. Patients: The subjects were from different hospitals including: Peking Union Medical College Hospital (PUMCH).

Study arrangement:

This study was consisted of three parts:

Condition or disease
Cirrhosis Hepatic Carcinoma

Study Design

Study Type : Observational
Estimated Enrollment : 0 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Functional-three-dimensional Reconstruction and Functional Evaluation of Liver by 99MTc-GSA-SPECT Scintigraphy
Study Start Date : January 2008
Primary Completion Date : May 2011
Estimated Study Completion Date : July 2011

Groups and Cohorts

Normal control
Subjects without liver cirrhosis and normal volunteers.
Cirrhosis group
Subjects with liver cirrhosis.

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
The subjects were from Peking Union Medical College Hospital from May, 2008 to the end of the study.

Inclusion Criteria:

  • Patients that with benign tumor、hepatitis and hepatic carcinoma (with or without cirrhosis)diagnosed by examination of CT, ultrasound-B, and/or pathology.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01350726

China, Beijing
Peking Union Medical College Hospital Recruiting
Beijing, Beijing, China, 100730
Contact: Yilei Mao, M. D, Ph. D    +86-10-65296042    pumch.liver@hotmail.com   
Principal Investigator: Yilei Mao, M. D, Ph. D         
Sponsors and Collaborators
Peking Union Medical College Hospital
More Information

Responsible Party: Dr. Yilei Mao, Peking Union Medical College Hospital
ClinicalTrials.gov Identifier: NCT01350726     History of Changes
Other Study ID Numbers: PUMCH-Liver surgery -GSA
First Posted: May 10, 2011    Key Record Dates
Last Update Posted: May 10, 2011
Last Verified: May 2011

Keywords provided by Peking Union Medical College Hospital:
Hepatic Carcinoma

Additional relevant MeSH terms:
Carcinoma, Hepatocellular
Pathologic Processes
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Liver Diseases